October 5, 2020
The 3D reconstructed skin micronucleus assay: considerations for optimal protocol design
Implementation of the seventh amendment to the EU Cosmetics Directive has driven much research into suitable in vitro alternative assays to support satisfactory risk assessments. One such assay is the reconstructed skin micronucleus (RSMN) assay. First reported in 2006, further... Read More